KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to -$33.7 million.

  • Charles River Laboratories International's Cash from Investing Activities fell 5801.91% to -$33.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$192.6 million, marking a year-over-year increase of 5271.47%. This contributed to the annual value of -$245.1 million for FY2024, which is 5647.98% up from last year.
  • Charles River Laboratories International's Cash from Investing Activities amounted to -$33.7 million in Q3 2025, which was down 5801.91% from -$37.3 million recorded in Q2 2025.
  • Charles River Laboratories International's Cash from Investing Activities' 5-year high stood at $44.4 million during Q4 2022, with a 5-year trough of -$954.2 million in Q2 2021.
  • In the last 5 years, Charles River Laboratories International's Cash from Investing Activities had a median value of -$79.6 million in 2023 and averaged -$156.3 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first plummeted by 323330.89% in 2021, then surged by 37687.76% in 2022.
  • Quarter analysis of 5 years shows Charles River Laboratories International's Cash from Investing Activities stood at $9.3 million in 2021, then skyrocketed by 376.88% to $44.4 million in 2022, then crashed by 637.08% to -$238.4 million in 2023, then surged by 68.07% to -$76.1 million in 2024, then skyrocketed by 55.72% to -$33.7 million in 2025.
  • Its last three reported values are -$33.7 million in Q3 2025, -$37.3 million for Q2 2025, and -$45.5 million during Q1 2025.